XOSPATA (gilteritinib) tablets
XOSPATA is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test. FDA approved gilteritinib (brand name XOSPATA) is not (yet) registered or available in India but on request Indian patient can buy XOSPATA at the lowest price.
Home | gilteritinib
Submit a request to access drug used to treat, diagnose or prevent serious or life-threatening conditions.We’ll get back to you within 1 business days!
For Indian Patient Enquiry under NPP.
For any urgent inquiries or assistance needed, please reach out to our Support Team. Rest assured, we will respond within 24 hours, from Monday to Saturday, during the hours of 9:00 A.M to 18:00 PM.
XOSPATA (gilteritinib) tablets
a certain type of acute myeloid leukemia (AML) that has worsened or returned after treatment with other chemotherapy medications
XOSPATA is a kinase inhibitor indicated for the treatment of adult patients who have relapsed or refractory acute myeloid leukemia (AML) with a FLT3
mutation as detected by an FDA-approved test.
Gilteritinib, sold under the brand name Xospata, is an anti-cancer drug.[7] It acts as an inhibitor of FLT3, hence it is a tyrosine kinase inhibitor.
In April 2018, Astellas filed a new drug application with the Food and Drug Administration for gilteritinib for the treatment of adult patients with FLT3 mutation–positive relapsed or refractory acute myeloid leukemia (AML).
In November 2018, the FDA approved gilteritinib for treatment of adult patients with relapsed or refractory acute myeloid leukemia (AML) with a FLT3 mutation as detected by an FDA-approved test.
Gilteritinib was granted orphan drug status by the U.S. FDA, the European Commission (EC) and the Japan Ministry of Health, Labor and Welfare, for some AML patients. Gilteritinib was approved for medical use in Australia in March 2020.
Drug (Brand / Generic): XOSPATA / gilteritinib
Current Indication: treat a certain type of acute myeloid leukemia (AML)
Approval Date: 2018
ACOVAÔ (argatroban) Injection is supplied in 2.5 mL solution in single-use vials at the concentration of 100 mg/mL. Each vial contains 250 mg of argatroban.
Find Reference Updates
- For XOSPATA (gilteritinib) tablets And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions.
- Xospata dosage
- List ItemEuropean Commission Approves Astellas' XOSPATA™ (gilteritinib) as a Monotherapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia with a FLT3 Mutation
- Astellas' Xospata comes up short again in bid to expand leukemia use
For more highlights of prescribing information regarding Indications and usage, dosage and administration, dosage forms and strengths, patient counseling information and medication guide. Click Here
Alleviare Life Sciences
About Us
Alleviare Life Sciences Pvt. Ltd. (India) serves as a facilitator for medical and pharmaceutical products, commencing its operations in 2005. Headquartered in Delhi, India, Alleviare operates nationwide, providing a range of comprehensive services to patients, doctors, hospitals, and government healthcare facilities.
Our specialization lies in facilitating access to medicines, leveraging our expertise in sourcing and providing documentation assistance for programs such as Named Patient Program, Managed Access Program, and Early Access Program. We take pride in ensuring smooth and efficient access to medications for those who require them.
Alleviare India is certified pharmaceutical facilitator / supplier /importer based in india. They are also who GDP certified. One of the pharmaceutical products they offer is “ XOSPATA (gilteritinib) tablets ”. FDA approved gilteritinib (brand name XOSPATA) is not (yet) registered or available in India but on request Indian patient can buy XOSPATA at the lowest price. Confirmation of the order for XOSPATA (gilteritinib) tablets will be subject to the submission of a valid doctor’s prescription and, if applicable, an import permit.
Get Access to FDA approved gilteritinib (brand name XOSPATA) India.
For personal use, get access to FDA approved gilteritinib (brand name XOSPATA) India. On request, We have imported and delivered Anti-cancer medicines to following cities in India – Ahmedabad, Bangalore, Surat, Kolkata, Pune, Indore, Nagpur, Agra, Kanpur, Patna, Coimbatore, Kochi, Delhi, Gurugram, Amaravati, Itanagar, Dispur, Patna, Raipur, Panaji, Gandhinagar, Chandigarh, Shimla, Ranchi, Bengaluru, Thiruvananthapuram, Bhopal, Mumbai, Imphal, Shillong, Aizawl, Kohima, Bhubaneswar, Jaipur, Gangtok, Chennai, Hyderabad, Agartala, Lucknow, Dehradun, Gairsain. Aizawal, Aurangabad, Barshi, Cachar, Dibrugarh, Karungapally, Kollam, Meghalaya, Mizoram, Sikkim, Pondichery, Punjab, Tripura, New Delhi, Agra, Gurugram, Alwar, Mathura, Panipat, Faridabad, Noida, Sonipat, Rohtak, Karnal, Ambala, Ghaziabad.
XOSPATA Sourcing & Delivery
Alleviare India specializes in sourcing and supplying XOSPATA, a cancer treatment medicine, from around the world. They offer worldwide access to the best available treatment options. Alleviare India can dispense any valid prescription quickly and helps connect patients with potential distributors, wholesalers, suppliers, and dealers of XOSPATA in India.
How much does XOSPATA cost in the India?
Kindly reach out to us for XOSPATA (gilteritinib) tablets price and availability confirmation. The price of the medicines is the cost set by the manufacturer. In addition, Named Patient support fee, shipping costs and any local tax (if applicable) will apply.
What documents are required to import XOSPATA to India?
To import gilteritinib (brand name XOSPATA), patients or government hospitals can place an order on behalf of the patients.
The following documentation is required for the import process:
- Valid prescription from a qualified doctor.
- Patients’ diagnostic reports.
- Patients’ ID proof issued by the Government of India.
The order will be confirmed only after the receipt of the following:
- Valid prescription from the doctor.
- Import permit, if applicable.
Please ensure that all the necessary documentation is provided to confirm the order.
Is gilteritinib (brand name XOSPATA) available in India?
On November 28, 2018, the FDA approved gilteritinib (Xospata; Astellas), a small-molecule FMS-like tyrosine kinase 3 (FLT3) inhibitor, for treatment of relapsed or refractory acute myeloid leukemia with a FLT3 mutation as detected by an FDA-approved test.
Please contact or mail @ – info@alleviareindia.com +91 9289711087 / 9289711088 for XOSPATA availability and prices in India. We guarantee the authenticity and quality of our products and offer worldwide delivery according to the buyer’s specifications.
Is gilteritinib available in India?
Yes, FDA approved gilteritinib (brand name XOSPATA) is not (yet) registered or available in India but on request Indian patient can buy XOSPATA at the lowest price. Alleviare will help patient / doctor to get in India.
How overseas patient can get access?
ALS serves as a facilitator, supplier & exporter in India assisting patients, doctors, and hospitals in importing the prescription medicine brand XOSPATA (gilteritinib) tablets . The import process requires a valid prescription and an Import License in the Patient’s Name.
For patients from following foreign countries seeking access to XOSPATA (gilteritinib) tablets , they can inquire and find further information by sending their inquiries to ALS.
